Neutropenia
Research from J.A. Oshaughnessy et al has provided new information about neutropenia
Published in Blood Weekly, March 6th, 2008
According to recent research from the United States, "Although substantial progress has been made in optimizing the adjuvant treatment of breast cancer, many of the most important proven agents carry a risk for potentially severe toxicity. Taxanes can cause febrile neutropenia and related serious infections, and anthracyclines and trastuzumab are associated with a small risk of clinically significant cardiac toxicity."
"These adverse events can limit the ability to deliver adjuvant treatment because of needed dose reductions and scheduling delays, which may attenuate the effectiveness of regimens designed to improve survival or cure patients with early-stage breast...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-03-06)
More Articles from Blood Weekly
- Acidosis
Research in the area of acidosis reported from Maulana Azad Medical College, Medical College - Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley
Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation - Breast Cancer
Abviva Announces Patent Issuance for Core Technology Used in Mammastatin Serum Assay Diagnostic Test for Breast Cancer - Cancer
Plexxikon Announces Publication of Key Data Demonstrating Possible Personalized Medicine for a Variety of Cancers - Dengue Fever
Reports outline dengue fever study findings from M.T. Cordeiro and colleagues - Dengue Fever
Studies from University of Rochester yield new information about dengue fever - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
